‹ ASND latest research

ASND (Ascendis Pharma A/S): every AI call and what happened next

TradeFlare's AI research teams analysed ASND on 9 market nights between May 28, 2026 and September 18, 2026. Each row is that night's verdict, the price that day, and how the price actually moved afterwards — wins and misses alike. Nothing is edited after the fact.

9 calls 8 BUY · 1 HOLD · 0 SELL BUY calls up after 20 trading days: 5 of 8
DateVerdictPriceTarget / stop5 days later20 days laterWhy (that night)
September 18, 2026 HOLD $239.04 $274.89 / $203.18 -4.7% not yet
The stock is consolidating and the technicals are neutral, suggesting a period of observation is warranted before a directional move.
August 18, 2026 BUY $247.40 — / — +1.7% -0.5%
Strong Q2 earnings beat and positive trial data for YUVIWEL.
August 17, 2026 BUY $248.50 — / — +1.8% -3.1%
Positive news sentiment driven by strong Q2 earnings and successful product uptake.
August 14, 2026 BUY $246.23 $295.48 / $209.30 +1.9% +6.6%
The post-earnings drift signal suggests a multi-week upward trend.
July 31, 2026 BUY $251.07 — / — +4.7% +1.6%
The current market regime and stock-specific factors do not support a new entry at this time.
July 21, 2026 BUY $251.76 — / — -0.3% -2.5%
The current market and stock-specific technicals do not support a buy recommendation.
June 4, 2026 BUY $216.79 — / — -1.5% +22.4%
The market regime is neutral, and the technical analysis is bearish, overriding the bullish fundamental and sentiment signals for a buy recommendation.
June 2, 2026 BUY $218.82 — / — -1.6% +23.6%
The stock is in a neutral technical state with conflicting momentum signals, and while sentiment is bullish, fundamental risks are significant.
May 28, 2026 BUY $235.26 — / — -7.8% +9.8%
The current market regime is neutral, and while there is insider buying, the technicals are neutral and the risk score is high.

Prices are daily closes. "Days later" counts trading days from the close on the day of the call. A HOLD is not a recommendation to buy; only published signals are tracked with a target and stop on the public record. How the research works. Updated October 14, 2026. AI-generated research for educational purposes — it can be wrong and is not financial advice.